Home » Newsletters » BioWorld Science

BioWorld Science

March 25, 2022

View Archived Issues

"Trojan horse" approach redirects tetanus immune response to tumors

Researchers unveil novel markers of GABA catabolism pathway abnormalities

Roche patents compounds for Gram-negative bacterial infections

German researchers divulge nitric oxide production inhibitors

Medshine Discovery presents new antifungal compounds

Gasherbrum Bio identifies GLP-1 receptor agonists

Aubrak Therapeutics patents new PROTACs for cancer

Regulus miR-155 inhibitors studied to treat ALS

Chugai gains access to Halozyme's ENHANZE drug delivery technology

BiondVax collaborates with Max Planck and UMG for development of NanoAbs

Insilico Medicine and EQRx enter drug discovery and development collaboration

PPARgamma isoforms have specific and separable roles in gene regulation and metabolism

Predictive Oncology validates Discovery 21 results

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...